Biocartis

Biocartis, founded in 2007 and headquartered in Mechelen, Belgium, is a specialized molecular diagnostics company. It develops and provides automated instruments for detection, data analysis, and reporting, serving the pharmaceutical and healthcare industries. Operating within the Test & Measurement Equipment and Manufacturing sectors, Biocartis leverages advanced technology to enhance diagnostic capabilities and medical insights across Europe. The company's strategic focus is on delivering innovative solutions that support critical healthcare needs.

With a dedicated team of 500-1,000 employees spread across two locations, Biocartis is committed to advancing diagnostic precision. Its core offering includes the idylla™ platform, a versatile system designed for molecular diagnostic tests, notably supporting cancer testing and the development of personalized medicine. This platform facilitates rapid and accurate clinical reporting, empowering healthcare professionals. For a closer look at the company's personnel and structure, one can Meet Biocartis's team. Biocartis generates $53.0M in revenue, underscoring its operational scale and market presence.

The company's product suite is engineered for universal access and ease of use, enabling key medical assessments and supporting the generation of comprehensive annual reports. Biocartis's commitment extends to providing proprietary solutions that contribute to personalized medicine and improved patient outcomes. The firm's technological advancements aim to streamline diagnostic workflows and enhance the efficiency of clinical laboratories, positioning it as a key player in the European molecular diagnostics landscape.